http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Edwards SAPIEN 3 Valve Receives FDA Approval For Aortic, Mitral Valve-In-Valve Procedures
-
Edwards Lifesciences' Every Heartbeat Matters Initiative On Track To Impact 1 Million Underserved People By 2020
-
Edwards' Novel Self-Expanding Transcatheter Heart Valve Demonstrates Excellent Early Patient Outcomes
-
Real-World Evidence With Edwards SAPIEN 3 Transcatheter Valve Confirms Beneficial Patient Outcomes From Clinical Trials
-
Edwards Lifesciences To Webcast Annual Meeting Of Stockholders
-
Edwards Lifesciences To Present At The Deutsche Bank 42nd Annual Health Care Conference
-
Pre-Open Stock Movers 04/26: (AKBA) (IRTB) (TWTR) Higher; (X) (STX) (CREE) Lower (more...)
-
Edwards Lifesciences Reports First Quarter Results
-
Edwards Lifesciences (EW) Announces FDA Clearance for Advanced Hemodynamic Monitoring Platform
-
Edwards' Advanced Hemodynamic Monitoring Platform Receives FDA Clearance
-
Edwards Lifesciences To Host Earnings Conference Call On April 25, 2017
-
Edwards Lifesciences (EW) Announces German Court Ruled Boston Scientific's (BSX) Lotus Valve Infringes One Patents but Does Not Infringe Second
-
German Patent Court Issues Initial Decision
-
Edwards Lifesciences (EW) Says UK Patent Court's Initial Decision on Boston Scientific's (BSX) Patents Finds One Invalid, Second Infringed
-
UK Patent Court Issues Initial Decision
-
Edwards Lifesciences Reports Fourth Quarter Results
-
Edwards Lifesciences Completes Acquisition Of Valtech Cardio
-
Edwards Lifesciences To Host Earnings Conference Call On February 1, 2017
-
Edwards Lifesciences To Present At The 35th Annual J.P. Morgan Healthcare Conference
-
Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference
-
Edwards Lifesciences (EW) to Acquire Valtech Cardio; Adds $1B to Stock Buyback Plan
-
Edwards Enters Into Agreement To Acquire Valtech Cardio
-
Edwards Lifesciences (EW) Announces Strong Five-Year Data from PARTNER Trial
-
Edwards Sapien Valves Demonstrate Excellent Durability In 5-Year Echo Study
-
Early And Sustained Quality Of Life Improvements Seen For Intermediate Risk Patients Treated With Edwards Transcatheter Valves
-
Pre-Open Stock Movers 10/26: (OGXI) (AKAM) (IRBT) Higher; (EW) (NUVA) (P) (CMG) (AAPL) Lower (more...)
-
Edwards Lifesciences Reports Third Quarter Results
-
Edwards Lifesciences To Host Earnings Conference Call On October 25, 2016
-
Edwards Lifesciences (EW) Announces Receipt of CE Mark for Acumen HPI
-
Edwards Receives CE Mark For Hypotension Probability Indicator
-
Edwards Lifesciences (EW) Received CE Mark for INSPIRIS RESILIA Aortic Valve
-
Edwards INSPIRIS RESILIA Valve Receives CE Mark
-
Edwards Lifesciences (EW) Announces Sapien 3 Receives Expanded Indication In Europe
-
Edwards Sapien 3 Transcatheter Heart Valve Receives Expanded Indication In Europe
-
Edwards Lifesciences (EW) Announces Expanded Indication From FDA for SAPIEN 3 Transcatheter Heart Valve
-
Edwards SAPIEN 3 Transcatheter Heart Valve Receives Expanded Indication From FDA
-
EDWARDS INTUITY Elite Rapid Deployment Valve Receives FDA Approval
-
Pre-Open Stock Movers 07/27: (SQNM) (LOGI) (AAPL) Higher; (GMED) (AKAM) (TWTR) Lower (more...)
-
After-Hours Stock Movers 07/26: (LOGM) (AAPL) (EW) Higher; (TWTR) (AKAM) (MTCH) Lower (more...)
-
Edwards Lifesciences Reports Second Quarter Results
-
Edwards Lifesciences To Host Earnings Conference Call On July 26, 2016
-
Edwards Lifesciences (EW) Adds New Board Member
-
Leslie Heisz Appointed To Edwards Lifesciences Board Of Directors
-
Edwards Lifesciences To Present At Goldman Sachs 37th Annual Global Healthcare Conference
-
Edwards Lifesciences (EW) Announces Receipt of Favorable CardiAQ Verdict in Neovasc Litigation
-
Jury Finds in Favor of CardiAQ in Case with Neovasc
-
Edwards' Surgical Heart Valve Innovations Demonstrate Positive Patient Benefits
-
Edwards SAPIEN 3 Transcatheter Valve Demonstrates Positive Patient Outcomes At 30 Days In European Real-World Experience
-
Edwards Lifesciences' Philanthropy Impacts 200,000 Underserved Patients Through Every Heartbeat Matters Initiative
-
Edwards Lifesciences To Webcast Annual Meeting Of Stockholders

